Simon Meier

IDUN Technologies is a neurotech Start Up and our vision is to create a more connected and empathetic world using in-ear EEGs. Our Guardian brain analytics platform is a Brain-computer Interface that provides real time measurements of neuromarkers, enabling partners to improve their products and services using innovative technology. Since spinning out of the ETH Start Up programme we have been pursuing opportunities in the fields of sleep, hearing health and wellbeing and are currently running PoCs with partners in those fields. If you would like to know more or get involved in a PoC then please reach out to us here, our co-founders Simon Bachmann and Severine Gisin, or visit our website.

Viewics (Acquired by Roche) provides unprecedented access to disparate healthcare data to surface actionable intelligence and empower data-driven decision-making. Through expertise and focus on healthcare analytics, Viewics delivers proprietary, best-in-class technology for data extraction, cleansing, and transformation to quickly unlock insights that deliver invaluable operational and financial impact, while reducing burden on IT. The HIPAA-compliant solution puts the transformational power of analytics into the hands of healthcare professionals in financial, operational, and IT roles. The solution is customized and supported to enable organizations to move with agility, make decisions based on accurate data, see insights at-a-glance, and deliver great impact.

mySugr specializes in app-based, all-around care for people with diabetes made by people with diabetes. Our digital diabetes solution combines diabetes coaching, therapy management, diabetes supplies, automated data tracking, and seamless integration with a growing number of medical devices to ease the daily burden of living with diabetes. mySugr creates simple, effective solutions that serve people with diabetes, as well as organizations that manage populations with diabetes.

IDUN Technologies is a neurotech Start Up and our vision is to create a more connected and empathetic world using in-ear EEGs. Our Guardian brain analytics platform is a Brain-computer Interface that provides real time measurements of neuromarkers, enabling partners to improve their products and services using innovative technology. Since spinning out of the ETH Start Up programme we have been pursuing opportunities in the fields of sleep, hearing health and wellbeing and are currently running PoCs with partners in those fields. If you would like to know more or get involved in a PoC then please reach out to us here, our co-founders Simon Bachmann and Severine Gisin, or visit our website.

Healthcare & Technology Venture Capital since 2001. Vi Partners is the longest-established Swiss Venture Capital firm. For more than 20 years, Vi Partners has been supporting innovative Technology and Healthcare companies, investing over CHF 330m in 70 startups. Vi Partners-managed funds are backed by Switzerland’s most visible companies and institutions, including ETH Zurich, ABB, Buhler, Credit Suisse, Hilti, McKinsey, Nestlé, Schindler, Sulzer, Suva and ZKB as well as the European Investment Fund and many other institutional investors. Security Notice: Vi Partners does not solicit payments, or conduct business via private messaging apps. All legitimate engagement is initiated exclusively from @vipartners.ch email addresses.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Viewics (Acquired by Roche) provides unprecedented access to disparate healthcare data to surface actionable intelligence and empower data-driven decision-making. Through expertise and focus on healthcare analytics, Viewics delivers proprietary, best-in-class technology for data extraction, cleansing, and transformation to quickly unlock insights that deliver invaluable operational and financial impact, while reducing burden on IT. The HIPAA-compliant solution puts the transformational power of analytics into the hands of healthcare professionals in financial, operational, and IT roles. The solution is customized and supported to enable organizations to move with agility, make decisions based on accurate data, see insights at-a-glance, and deliver great impact.

mySugr specializes in app-based, all-around care for people with diabetes made by people with diabetes. Our digital diabetes solution combines diabetes coaching, therapy management, diabetes supplies, automated data tracking, and seamless integration with a growing number of medical devices to ease the daily burden of living with diabetes. mySugr creates simple, effective solutions that serve people with diabetes, as well as organizations that manage populations with diabetes.